Items where authors include "Battaglia, S."

Article

Moukengue, B., Brown, H.K., Charrier, C. et al. (11 more authors) (2020) TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model. EBioMedicine, 53. 102704. ISSN 2352-3964

Camuzard, O., Santucci-Darmanin, S., Breuil, V. et al. (9 more authors) (2016) Sex-specific autophagy modulation in osteoblastic lineage: a critical function to counteract bone loss in female. Oncotarget. ISSN 1949-2553

Cordova, L.A., Guilbaud, F., Amiaud, J. et al. (6 more authors) (2016) Severe Compromise of Preosteoblasts in a Surgical Mouse Model of Bisphosphonate-Associated Osteonecrosis of the Jaw. Journal of Craniomaxillofacial Surgery, 44 (9). pp. 1387-1394. ISSN 1010-5182

Ory, B., Baud'huin, M.E., Verrecchia, F. et al. (7 more authors) (2016) Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression. Clinical Cancer Research, 22 (10). pp. 2520-2533. ISSN 1078-0432

Beranger, G.E., Djedaini, M., Battaglia, S. et al. (5 more authors) (2015) Oxytocin reverses osteoporosis in a sex-dependent manner. Frontiers in Endocrinology, 6. 81.

Gobin, B., Baud'Huin, M., Lamoureux, F. et al. (8 more authors) (2015) BYL719, a new alpha-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. International Journal of Cancer, 136 (4). pp. 784-796. ISSN 0020-7136

Cordova, L.A., Trichet, V., Escriou, V. et al. (10 more authors) (2015) Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomaterialia, 13. pp. 150-158. ISSN 1742-7061

Nollet, M., Santucci-Darmanin, S., Breuil, V. et al. (19 more authors) (2014) Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy, 10 (11). pp. 1965-1977. ISSN 1554-8627

Lezot, F., Chesneau, J., Battaglia, S. et al. (5 more authors) (2014) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. BONE, 68. pp. 146-152. ISSN 8756-3282

Beranger, G.E., Pisani, D.F., Castel, J. et al. (9 more authors) (2014) Oxytocin Reverses Ovariectomy-Induced Osteopenia and Body Fat Gain. Endocrinology, 155 (4). pp. 1340-1352. ISSN 0013-7227

Gobin, B., Battaglia, S., Lanel, R. et al. (5 more authors) (2014) NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate. Cancer Letters, 344 (2). pp. 291-298. ISSN 0304-3835

Odri, G., Kim, P-P., Lamoureux, F. et al. (6 more authors) (2014) Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migration. BMC Cancer, 14. 169. ISSN 1471-2407

Heymann, M-F., Herisson, F., Davaine, J-M. et al. (6 more authors) (2012) Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds. Cytokine, 58 (2). pp. 300-306. ISSN 1043-4666

Rousseau, J., Escriou, V., Lamoureux, F. et al. (8 more authors) (2011) Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models. Journal of Bone and Mineral Research, 26 (10). pp. 2452-2462. ISSN 0884-0431

Battaglia, S., Dumoucel, S., Chesneau, J. et al. (6 more authors) (2011) Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient. Journal of Bone and Mineral Research, 26 (10). pp. 2439-2451. ISSN 0884-0431

Herisson, F., Heymann, M-F., Chetiveaux, M. et al. (8 more authors) (2011) Carotid and femoral atherosclerotic plaques show different morphology. Atherosclerosis, 216 (2). pp. 348-354. ISSN 0021-9150

David, E., Guihard, P., Brounais, B. et al. (10 more authors) (2011) Direct anti-cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer, 128 (8). pp. 1822-1835. ISSN 0020-7136

Moriceau, G., Ory, B., Mitrofan, L. et al. (11 more authors) (2010) Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research, 70 (24). pp. 10329-10339. ISSN 0008-5472

Odri, G.A., Dumoucel, S., Picarda, G. et al. (10 more authors) (2010) Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients. Cancer Research, 70 (19). pp. 7610-7619. ISSN 0008-5472

Mori, K., Blanchard, F., Charrier, C. et al. (6 more authors) (2008) Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk. Cancer Science, 99 (11). pp. 2170-2176. ISSN 1347-9032

Lamoureux, F., Picarda, G., Rousseau, J. et al. (6 more authors) (2008) Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Molecular Cancer Therapeutics, 7 (10). pp. 3389-3398. ISSN 1535-7163

Brounais, B., Chipoy, C., Mori, K. et al. (7 more authors) (2008) Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of midostaurin in vivo. Clinical Cancer Research, 14 (17). pp. 5400-5409. ISSN 1078-0432

Heymann, M-F., Riet, A., Le Goff, B. et al. (3 more authors) (2008) OPG, RANK and RANK ligand expression in thyroid lesions. Regulatory Peptides, 148 (1-3). pp. 46-53. ISSN 0167-0115

Lamoureux, F., Ory, B., Battaglia, S. et al. (6 more authors) (2008) Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid. International Journal of Cancer, 122 (4). pp. 751-760. ISSN 0020-7136

Chipoy, C., Brounais, B., Trichet, V. et al. (7 more authors) (2007) Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene, 26 (46). pp. 6653-6664. ISSN 0950-9232

Lamoureux, F., Richard, P., Wittrant, Y. et al. (8 more authors) (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: Blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Research, 67 (15). pp. 7308-7318. ISSN 0008-5472

Mori, K., Le Goff, B., Charrier, C. et al. (3 more authors) (2007) DU145 human prostate cancer cells express functional receptor activator of NF kappa B: New insights in the prostate cancer bone metastasis process. Bone , 40 (4). pp. 981-990. ISSN 8756-3282

Ory, B., Blanchard, F., Battaglia, S. et al. (3 more authors) (2007) Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. Molecular Pharmacology, 71 (1). pp. 333-343. ISSN 0026-895X